Impact of diabetes on left ventricular diastolic function in patients with arterial hypertension

European Journal of Heart Failure

Volumn 9, Issue 5, 2007, Pages 469-476

  Wachter, Rolf ^a   Lüers, Claus ^a   Kleta, Sibylle ^a   Griebel, Kerstin ^a   Herrmann Lingen, Christoph ^b   Binder, Lutz ^a   Janicke, Nico ^a   Wetzel, Dirk ^a   Kochen, Michael M ^a   Pieske, Burkert ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Diabetes; Diastolic function; Echocardiography; Heart failure

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLE; DIASTOLIC DYSFUNCTION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREVALENCE; PRIORITY JOURNAL; SYSTOLE;

AGED; BLOOD PRESSURE; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS, TYPE 2; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 34147140480     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2007.01.001     Document Type: Article

References (31)

1. Garcia M.J., McNamara P.M., Gordon T., and Kannel W.B. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 23 (1974) 105-111
2. Kannel W.B., Hjortland M., and Castelli W.P. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34 (1974) 29-34
3. Lundbaek K. Diabetic angiopathy: a specific vascular disease. Lancet 266 (1954) 377-379
4. Galderisi M., Anderson K.M., Wilson P.W., and Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (The Framingham Heart Study). Am J Cardiol 68 (1991) 85-89
5. Schannwell C.M., Schneppenheim N., Perings S., Plehn G., and Strauer B.E. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology 98 (2002) 33-39
6. Poirier P., Bogaty P., Garneau C., Marois L., and Dumesnil J.G. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of manoeuvres in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 24 (2001) 5-10
7. Devereux R.B., Roman M.J., Paranicas M., et al. Impact of diabetes on cardiac structure and function: the strong heart study. Circulation 101 (2000) 2271-2276
8. Schafer S., Huber J., Wihler C., Rutten H., Busch A.E., and Linz W. Impaired left ventricular relaxation in type 2 diabetic rats is related to myocardial accumulation of N(epsilon)-(carboxymethyl) lysine. Eur J Heart Fail 8 (2006) 2-6
9. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
10. Cheitlin M.D., Armstrong W.F., Aurigemma G.P., et al. ACC/AHA/ASE 2003 Guideline update for the clinical application of echocardiography: a report of the American College of Cardiology/American Heart Association Task force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography) (2003). http://www.acc.org/clinical/guidelines/echo/index.pdf American College of Cardiology Web site. Available at: www.acc.org/clinical/guidelines/echo/index.pdf
11. Quinones M.A., Otto C.M., Stoddard M., Waggoner A., and Zoghbi W.A. Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 15 (2002) 167-184
12. Dokainish H., Zoghbi W.A., and Lakkis N.M. Optimal non-invasive assessment of left ventricular filling pressures. A comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters. Circulation 109 (2004) 2432-2439
13. Liu J.E., Palmieri V., Roman M.J., et al. The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol 37 (2001) 1943-1949
14. Hildebrandt P., Wachtell K., Dahlof B., et al. Impairment of cardiac function in hypertensive patients with Type 2 diabetes: a LIFE study. Diabet Med 22 (2005) 1005-1011
15. Zabalgoitia M., Ismaeil M.F., Anderson L., and Maklady F.A. Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am J Cardiol 87 (2001) 320-323
16. von Bibra H., Thrainsdottir I.S., Hansen A., Dounis V., Malmberg K., and Ryden L. Tissue Doppler imaging for the detection and quantification of myocardial dysfunction in patients with type 2 diabetes mellitus. Diab Vasc Dis Res 2 (2005) 24-30
17. Redfield M.M., Jacobsen S.J., Burnett Jr. J.C., Mahoney D.W., Bailey K.R., and Rodeheffer R.J. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289 (2003) 194-202
18. Rutter M.K., Parise H., Benjamin E.J., et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation 107 (2003) 448-454
19. 2+exchanger increases susceptibility to ischemia/reperfusion injury in male, but not female, transgenic mice. Circ Res 83 (1998) 1215-1223
20. Du X.J., Samuel C.S., Gao X.M., Zhao L., Parry L.J., and Tregear G.W. Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype. Cardiovasc Res 57 (2003) 395-404
21. Gueyffier F., Boutitie F., Boissel J.P., et al. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. Ann Intern Med 126 (1997) 761-767
22. Wing L.M., Reid C.M., Ryan P., et al. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 348 (2003) 583-592
23. Kannel W.B., and McGee D.L. Diabetes and cardiovascular disease. The Framingham study. JAMA 241 (1979) 2035-2038
24. Pocock S.J., Wang D., Pfeffer M.A., et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 27 (2006) 65-75
25. Gottdiener J.S., Arnold A.M., Aurigemma G.P., et al. Predictors of congestive heart failure in the elderly: the cardiovascular health study. J Am Coll Cardiol 35 (2000) 1628-1637
26. von Bibra H., Hansen A., Dounis V., Bystedt T., Malmberg K., and Ryden L. Augmented metabolic control improves myocardial diastolic function and perfusion in patients with non-insulin-dependent diabetes. Heart 90 (2004) 1483-1484
27. Redfield M.M., Jacobsen S.J., Borlaug B.A., Rodeheffer R.J., and Kass D.A. Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation 112 (2005) 2254-2262
28. Regan T.J., Lyons M.M., Ahmed S.S., et al. Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 60 (1977) 884-899
29. Saraiva R.M., Duarte D.M., Duarte M.P., et al. Tissue Doppler imaging identifies asymptomatic normotensive diabetics with diastolic dysfunction and reduced exercise tolerance. Echocardiography 22 (2005) 561-570
30. Young M.E., McNulty P., and Taegtmeyer H. Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms. Circulation 105 (2002) 1861-1870
31. Van Hoeven K.H., and Factor S.M. A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. Circulation 82 (1990) 848-855